Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The promise of glucagon-like peptide 1 receptor agonists (GLP-1RA) for the treatment of obesity: a look at phase 2 and 3 pipelines
These powerful, evidence-based solutions belong to a class of medications known as GLP-1 receptor agonists that mimic a naturally occurring bodily hormone
Choquette et al.s 6-month intervention (3 sessions/week of combined resistance and aerobic exercise) in overweight/obese postmenopausal women found no improvements in whole-body, lumbar spine, or hip BMD (including total hip, femoral neck, trochanter, and Wards triangle)
This provides some continued effect, though reduced compared to consistent dosing
US$ 25.81
US$ 27.37
US$ 20.16
US$ 28.95
US$ 23.31
